956P - A phase Ib and randomised phase II trial of pazopanib with or without fosbretabulin in advanced recurrent ovarian cancer

Autor: Morgan, R.D., Jayson, G.C., Banerjee, S., Clamp, A.R., Lyon, A.R., Ryder, W.D., Hutson, R., Mescallado, N., Orbegoso Aguilar, C., Taylor, S., Tugwood, J., Hall, M., Dive, C., Rustin, G.J.S.
Zdroj: In Annals of Oncology October 2018 29 Supplement 8
Databáze: ScienceDirect